舒泰神股价跌5.01%，金鹰基金旗下1只基金重仓，持有51.21万股浮亏损失91.15万元

Core Viewpoint - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. experienced a decline of 5.01% in stock price, closing at 33.75 CNY per share, with a trading volume of 8.12 billion CNY and a turnover rate of 5.19%, resulting in a total market capitalization of 16.125 billion CNY [1] Group 1: Company Overview - Shuyou Shen was established on August 16, 2002, and went public on April 15, 2011. The company is primarily engaged in the research, production, and sales of biological products and some chemical drugs [1] - The main revenue sources for Shuyou Shen include: 59.17% from injectable mouse nerve growth factor (Sutai Sheng), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2: Fund Holdings - Jin Ying Fund has a significant holding in Shuyou Shen, with its Jin Ying Medical Health Stock A (004040) holding 512,100 shares, accounting for 5.14% of the fund's net value, making it the sixth-largest holding [2] - The estimated floating loss for the fund today is approximately 911,500 CNY [2] Group 3: Fund Manager Performance - The fund manager for Jin Ying Medical Health Stock A is Han Guangzhe, who has a tenure of 12 years and 342 days, with a total fund asset size of 1.909 billion CNY. The best fund return during his tenure is 55.35%, while the worst is -56.49% [3] - Co-manager Ouyang Juan has a tenure of 3 years and 27 days, managing assets of 456 million CNY, with a best return of 0.05% and a worst return of -30.47% during her tenure [3]